Zacharoula Sidiropoulou, Research GEIGS Euro-Team Leader at Gender Equity Initiative in Global Surgery (GEIGS), shared on LinkedIn:
“Day 1 at the European Cancer Summit 2026 in Brussels.
Day 1 started on a very good note, unexpectedly sharing the same train to Brussels with Christos Tsagkaris and later catching up with Vasco Fonseca!
A good reminder that some of the best parts of these meetings happen between or even before the sessions.
We had a full first day with a question coming back:
How do we build cancer care that is not only better, but fairer?

A few things I am taking away from today:
Cancer control is an investment, not simply a cost.
- The discussion on return on investment, a useful reminder that spending wisely across the whole pathway, from prevention, diagnosis, treatment and survivorship, has impact and consequences far beyond healthcare budgets.
Prevention still matters enormously.
- From HPV and Hepatitis B-related cancers to tobacco control and screening, some of the biggest gains available to Europe are still in things we already know how to do, if we implement them well and equitably.
Innovation is moving quickly. Access is not always moving with it.
- AI, shared data and digital pathology can improve diagnosis and efficiency. But, who actually benefits first? Who gets the responsibility? Is it right to train commercial models during real workloads and with real patient data?
Europe wants to remain a leader in clinical research.
- That means making trials faster and smarter but also making sure participation does not remain concentrated in the same centres and the same populations. I didn´t got convinced by the new plan proposed….
Launch of the updated European Code of Cancer Practice
- An important reminder that progress in oncology is not only about what we can do technically, but also about what patients should be able to expect from us.
What I liked most today was that competitiveness, innovation and equity were not treated as separate conversations and they should not be. A stronger European cancer system is one that innovates and makes sure that innovation reaches the people who need it.
Thank you to the European Cancer Organisation , the Summit co-chairs Isabel Rubio, Wim Ceeleneelen and Gilliosa Spurrier-Bernard, and all the speakers for such a stimulating first day!”
You may also be interested in:
Zacharoula Sidiropoulou: ESMO 2026 Interview on the Future of Personalised Breast Cancer Care